October 31,Opening of the 112nd Canton Fair Medical Insurance Exhibition。China Medical Insurance Chamber of Commerce (hereinafter referred to as the Medical Protection Chamber of Commerce),In the first three quarters of 2012, my country's foreign trade foreign trade import and export volume was US $ 69.86 billion,increased by 11.4%year -on -year. Among them,,Exit 35.35 billion US dollars,increased by 7.8%; imports were US $ 24.51 billion,Growing 17.0%. Emerging market growth is strong。

    Growth accident declines

    Compared with the growth rate of more than 20%in previous years,The growth rate of the import and export of pharmaceutical foreign trade this year fell significantly。& ldquo; Under the current severe economic environment and the conditions of rigorous domestic and foreign regulatory environment,my country's medical foreign trade still maintains growth,and higher than the average growth rate of the national foreign trade,Explain that the entire industry has made great efforts。But it is inevitable that the growth rate is slower than in previous years。& rdquo; Deputy Secretary -General of the China Medical Protection Chamber of Commerce, Tan Shengcai emphasized。

    The decline in export increase is relatively large。January ~ September,The export number of Chinese medical insurance products increased by 6.10%,The average export price rises by 1.63%. It is understood,At the beginning of the year, the Medical Insurance Chamber of Commerce has taken into account this year's market risk,The estimation of the export increase is reduced to 10%~ 15%,But the performance My stake betting appof My stake betting appthe market is still unexpected,Medical Insurance Chamber of Commerce is expected to export an annual export growth of about 9%。Based on past experience,Medicine exports usually have a small peak at the end of each year,It is expected that the increase in import and export throughout the year may reach about 12%。

    Talking about Shengcai thought,This year's pharmaceutical foreign trade situation is determined by many factors。From the market perspective,The European and American market economy atrophism in the world's medical dominance,Large export growth is weak; the price competition caused by overcapacity due to overcapacity of the community has a greater impact on exports。At the same time,Main competitor India、Brazil and other countries have further reduced the international competitiveness of my country's pharmaceutical products。In addition,When the economic development is not prosperous,Trade protection and non -technical trade barriers will also increase,The development of pharmaceutical foreign trade will also form obstacles。

    Different products encountered different problems。As an exporter of exports of materials,Although the export of raw materials in my country is increasing,But the profit and amount increase significantly slowly。Preparation,Due to the lack of the original research variety with independent intellectual property rights,less international high -end certification enterprises,There is a certain difficulty in entering the European and American markets,It is mainly sold in the non -mainstream market,Small quantity,The price is relatively low。but,In recent years, multinational enterprises have invested in factories in China,Product Rebate European and American Market,It plays a significant role in the exit of the pull preparation。Chinese medicine aspect,Affected by cultural differences,Most of the mainstream markets still appear as dietary supplements,Limited development speed。But with the internationalization of the company's internationalization,Europe and America、Southeast Asia and other markets increased the recognition of traditional Chinese medicine,The potential for future development is huge。

    It is understood,The increase in production costs this year has prompted rising export prices,But the increase in export prices is lower than the increase in cost increase,There is no change in the profit status of the enterprise。& ldquo; At stake sports betting apppresent, Stake Sports Bettingthe domestic labor cost and raw material costs are in the rise stage,Profit of affecting pharmaceutical companies,Then it affects the company's re -investment、Pioneering for the pioneering,Sustainable development ability is affected。& rdquo;,In the past financial crisis,Pharmaceutical rigid demand is reflected in foreign trade,This is the same today,Compared with other industries,Pharmaceutical Foreign Trade will still continue to develop steadily,But short -term fluctuations are inevitable。

    Expand emerging market

    Recently a series of tax refund、Reduce business costs and increase foreign trade encouragement policies such as export credit insurance,Support to foreign trade enterprises。Because medical foreign trade accounts for relatively small,There is a certain difficulty in fighting for policy。The reporter visited the third exhibitor of the current Canton Fair,Many representatives said that buyers who attended the meeting significantly reduced,Especially European and American buyers。

    For preparation export companies,Emerging market buyers may not have bad news。Wu Jianqiang, manager of Ningbo Xicheng Pharmaceutical Department of Ningbo, frankly said frankly,Domestic preparations are all emerging markets,& ldquo; The current general plate is very small,But the market is very large,Just the registration cycle is longer,It takes time to strengthen the marketing network layout。

    & ldquo; It is reported,Sinochem Ningbo is currently registered,Various varieties increase,Therefore, the exit of the preparation is basically stable。

    Data disclosed by the Medical Insurance Chamber of Commerce,January ~ September,Chinese pharmaceutical products export to 221 countries and regions。Asia、Europe and North America are still the main export market in my country's pharmaceutical products,The proportion of exports is as high as 86%,Export volume continues to grow。Among them, the growth of emerging markets is stronger,The increase is 10%; the largest export increase to the Oceania,up to 21%,Show good growth vitality。

    It is understood,In recent years, medical and insurance business will encourage enterprises to increase the development of emerging markets。& ldquo; Emerging market size is smaller than traditional developed markets,But the growth potential is huge。& rdquo;

    Talking about the analysis of the sacrament pointed out,The characteristics of my country's pharmaceutical products determine the development of emerging My stake betting appmarkets。In the European and American Stake Sports Bettingmarket,Preparation development is quite difficult,and the development of emerging markets in recent years,The drug regulatory system and level of these countries are closer to the country,Recognize Chinese medicine certification documents。The Medical Insurance Chamber of Commerce has done a lot of work to help companies develop emerging markets,If you organize an enterprise to go to Africa、Recommended and exchanges in Russia and other places,All achieved good results。

    Chinese medicine potential to be digged

    From the export amount in the first three quarters of this year,The largest export growth of medical equipment,12.94%,Chinese medicine and western medicine exports increased by 7.20%and 4.95%, respectively.,Chinese medicine、Medical equipment and western medicine rose 16.42%respectively、5.32%and 2.43%.

    The high rise of the export price of Chinese medicine,Stimulate enthusiasm for exports of related enterprises again。Diao Liqun, the Minister of International Department of Tianjin Daren Jingwan Wanhong Pharmaceutical Co., Ltd., who participated in the Canton Fair,At present, domestic trade in the overall trade of the enterprise still occupies the main position,The proportion of foreign trade is small,& ldquo; We are further conducting product scientific research and technology development,Perform clinical research,Hope,Further explains the scientific mechanism of the classic prescriptions of traditional Chinese medicines,lay a solid foundation for expanding the international market。& rdquo;

    The reporter saw the representative of the Sichuan Good Doctor Pharmaceutical Group and Sichuan Chuan Daxi West China Pharmaceutical Co., Ltd. at the scene of the Canton Fair,According to the project manager of the Overseas Division of Doctor Pharmaceuticals, Sang Miao introduced,Good doctors' fist products Rehabilitation new series products are actively promoting markets in developed countries such as Europe and the United States,Currently actively preparing overseas medicine、Registration of health products。According to the introduction of Sun Bing, the International Trade Department of West China Pharmaceutical,Although the external situation affects foreign trade with some countries,But Hua West Pharmaceutical's fist product Guanyuan particles and customers are very stable,Basically not affected,The first participation in the Canton Fair is to hope to use more channels,Push the product to more international markets。

    stake sports betting appYou can see from the import exhibition area,Medical and health care companies in foreign and My stake betting appoverseas regions also see the potential of the domestic market,With the help of my country's policy on imports,Striving for the domestic market。

    Industry insiders pointed out,The overall situation of the foreign trade situation this year is not optimistic,It may even be more severe than expected,Although the pharmaceutical industry has signs of bottoming back in the first three quarters,But this year's total foreign trade may be worse。From an enterprise perspective,Some companies with a certain foreign trade foundation are stealing technology upgrades and transformations,Pharmaceuticals and Foreign Trade Corporations are also seeking integration resources,Give full play to its own advantages,Actively carry out business。It is recommended that more domestic trade companies must increase foreign trade expansion investment,This is the only way for today's enterprises。Because the overall pharmaceutical foreign trade began to face the low -cost competition in emerging markets,,Transformation and upgrade seems very urgent。